Insider · CIK 0001860279

Wang Julia Aijun

Reports to the SEC for 2 companies · BURLINGTON, NC

sec.gov

Transactions

Companies

Filings

CIK

0001860279

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	+860 sh	—	—	2,062.239
2026-02-11	LHLABCORP HOLDINGS INC.F Tax Payment	Chief Financial Officer, EVP	FTax Payment	−245 sh	$289.89	−$71K	1,817.239
2026-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	−860 sh	—	—	4,964
2026-02-10	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsA Award	Chief Financial Officer, EVP	AAward	+7,100 sh	—	—	7,100
2026-02-10	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Chief Financial Officer, EVP	AAward	+2,350 sh	—	—	5,824
2026-02-06	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	+893 sh	—	—	1,456.239
2026-02-06	LHLABCORP HOLDINGS INC.F Tax Payment	Chief Financial Officer, EVP	FTax Payment	−254 sh	$277.20	−$70.4K	1,202.239
2026-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	−893 sh	—	—	3,474
2025-02-11	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsA Award	Chief Financial Officer, EVP	AAward	+7,800 sh	—	—	7,800
2025-02-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Chief Financial Officer, EVP	AAward	+2,580 sh	—	—	4,367
2025-02-06	LHLABCORP HOLDINGS INC.M Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	+893 sh	—	—	893
2025-02-06	LHLABCORP HOLDINGS INC.F Tax Payment	Chief Financial Officer, EVP	FTax Payment	−336 sh	$247.74	−$83.2K	557
2025-02-06	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	Chief Financial Officer, EVP	MExercise/Conversion	−893 sh	—	—	1,787
2024-12-02	LHLABCORP HOLDINGS INC. · Non-qualified Stock OptionsA Award	Chief Financial Officer, EVP	AAward	+8,100 sh	—	—	8,100
2024-12-02	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	Chief Financial Officer, EVP	AAward	+2,680 sh	—	—	2,680
2024-07-01	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−472 sh	$143.90	−$67.9K	0
2024-06-24	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−899 sh	$155.66	−$140K	0
2024-06-17	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−154 sh	$158.24	−$24.4K	762
2024-06-17	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−195 sh	$158.58	−$30.9K	567
2024-06-17	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−253 sh	$159.00	−$40.2K	314
2024-06-17	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−314 sh	$159.74	−$50.2K	0
2024-06-05	ONCBeOne Medicines Ltd.A Award	Chief Financial Officer	AAward	+136K sh	—	—	456,326
2024-06-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+257K sh	—	—	256,659
2024-02-29	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−397 sh	$167.08	−$66.3K	0
2023-07-03	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−472 sh	$179.55	−$84.7K	0
2023-06-23	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−840 sh	$182.85	−$154K	0
2023-06-20	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−190 sh	$192.54	−$36.6K	0
2023-06-15	ONCBeOne Medicines Ltd.A Award	Chief Financial Officer	AAward	+108K sh	—	—	342,303
2023-06-15	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+409K sh	—	—	409,058
2023-03-01	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−343 sh	$240.21	−$82.4K	0
2022-07-01	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−317 sh	$158.50	−$50.2K	0
2022-07-01	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−295 sh	$158.50	−$46.8K	0
2022-06-22	ONCBeOne Medicines Ltd.A Award	Chief Financial Officer	AAward	+104K sh	—	—	245,583
2022-06-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Chief Financial Officer	AAward	+590K sh	—	—	589,888
2022-06-17	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−161 sh	$136.64	−$22K	0
2022-02-28	ONCBeOne Medicines Ltd.A Award	Chief Financial Officer	AAward	+61.8K sh	—	—	143,299
2021-07-01	ONCBeOne Medicines Ltd.S Sale	Chief Financial Officer	SSale	−308 sh	$349.06	−$108K	0

Recent filings

Accepted (ET)
Feb 134
Wang Julia Aijun0000920148-26-000090
SEC(opens sec.gov)
Feb 124
Wang Julia Aijun0000920148-26-000066
SEC(opens sec.gov)
Feb 104
Wang Julia Aijun0000920148-26-000036
SEC(opens sec.gov)
Feb 134
Wang Julia Aijun0001127602-25-004529
SEC(opens sec.gov)
Feb 104
Wang Julia Aijun0001127602-25-003711
SEC(opens sec.gov)
Dec 44
Wang Julia Aijun0001127602-24-028581
SEC(opens sec.gov)
Jul 34
Wang Julia Aijun0001651308-24-000080
SEC(opens sec.gov)
Jun 264
Wang Julia Aijun0001651308-24-000079
SEC(opens sec.gov)
Jun 204
Wang Julia Aijun0001651308-24-000074
SEC(opens sec.gov)

Companies

Address

531 SOUTH SPRING STREET

BURLINGTON, NC, 27215